These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19466969)

  • 1. Enterovirus infection of neuronal cells post-Rituximab.
    Kiani-Alikhan S; Skoulidis F; Barroso A; Nuovo G; Ushiro-Lumb I; Breuer J; Lister A; Mattes F
    Br J Haematol; 2009 Aug; 146(3):333-5. PubMed ID: 19466969
    [No Abstract]   [Full Text] [Related]  

  • 2. Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma.
    Servais S; Caers J; Warling O; Frusch N; Baron F; De Prijck B; Beguin Y
    Br J Haematol; 2010 Aug; 150(3):379-81. PubMed ID: 20408837
    [No Abstract]   [Full Text] [Related]  

  • 3. Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy.
    Ganjoo KN; Raman R; Sobel RA; Pinto HA
    Leuk Lymphoma; 2009 Apr; 50(4):673-5. PubMed ID: 19373672
    [No Abstract]   [Full Text] [Related]  

  • 4. Enterovirus 71 meningoencephalitis complicating rituximab therapy.
    Ahmed R; Buckland M; Davies L; Halmagyi GM; Rogers SL; Oberste S; Barnett MH
    J Neurol Sci; 2011 Jun; 305(1-2):149-51. PubMed ID: 21444094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
    Quartier P; Tournilhac O; Archimbaud C; Lazaro L; Chaleteix C; Millet P; Peigue-Lafeuille H; Blanche S; Fischer A; Casanova JL; Travade P; Tardieu M
    Clin Infect Dis; 2003 Feb; 36(3):e47-9. PubMed ID: 12539090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.
    Sirvent-Von Bueltzingsloewen A; Sirvent N; Morand P; Cassuto JP
    Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818
    [No Abstract]   [Full Text] [Related]  

  • 7. Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma.
    Ozgönenel B; Moonka D; Savaşan S
    Am J Hematol; 2006 Apr; 81(4):302. PubMed ID: 16550511
    [No Abstract]   [Full Text] [Related]  

  • 8. Can rituximab change the usually dismal prognosis of patients with intravascular large B-cell lymphoma?
    Ferreri AJ; Dognini GP; Govi S; Crocchiolo R; Bouzani M; Bollinger CR; D'Incan M; Delaporte E; Hamadani M; Jardin F; Martusewicz-Boros M; Montanari M; Szomor A; Zucca E; Cavalli F; Ponzoni M
    J Clin Oncol; 2008 Nov; 26(31):5134-6; author reply 5136-7. PubMed ID: 18838697
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab in diffuse large B-cell lymphoma.
    Coiffier B
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):156-7. PubMed ID: 16166943
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-barr virus-positive diffuse large B-cell lymphoma during therapy with alemtuzumab for T-cell prolymphocytic leukemia.
    Sohani AR; Ferry JA; Chang PS; Abramson JS
    J Clin Oncol; 2010 Feb; 28(5):e69-72. PubMed ID: 19917859
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytomegalovirus gastritis after treatment with rituximab.
    Hasegawa Y; Goto A; Nishimura S; Sukawa Y; Fujii K; Suzuki K; Yonezawa K; Abe T; Shinomura Y; Yoshida Y
    Endoscopy; 2009; 41 Suppl 2():E199. PubMed ID: 19637127
    [No Abstract]   [Full Text] [Related]  

  • 12. An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.
    Mishima Y; Sugimura N; Matsumoto-Mishima Y; Terui Y; Takeuchi K; Asai S; Ennishi D; Asai H; Yokoyama M; Kojima K; Hatake K
    Clin Cancer Res; 2009 May; 15(10):3624-32. PubMed ID: 19417028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.
    Steurer M; Clausen J; Gotwald T; Gunsilius E; Stockhammer G; Gastl G; Nachbaur D
    Transplantation; 2003 Jul; 76(2):435-6. PubMed ID: 12883208
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactivation of hepatitis B after treatment with CHOP and rituximab].
    Fernández Fernández FJ; de la Fuente Aguado J; Puerta Louro R; Fernández Villaverde A; Soto Ríos C
    Rev Clin Esp; 2007 Apr; 207(4):220. PubMed ID: 17475194
    [No Abstract]   [Full Text] [Related]  

  • 16. Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma.
    Lai GG; Lim ST; Tao M; Chan A; Li H; Quek R
    Am J Hematol; 2009 Jul; 84(7):414-7. PubMed ID: 19415727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab.
    Schilthuizen C; Berenschot HW; Levin MD
    Neth J Med; 2010 May; 68(5):221-3. PubMed ID: 20508271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
    Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
    Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutropenic fever following chemotherapy in a patient with lymphoma.
    Book L
    Oncol Nurs Forum; 2008 Nov; 35(6):885-7. PubMed ID: 18980919
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab and chemotherapy in diffuse large B-cell lymphoma.
    Sonet A; Bosly A
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):719-26. PubMed ID: 19496708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.